Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Essential medicines and essential diagnostics: a package deal.

Pai M, Walia K, Boehme CC.

Lancet Public Health. 2019 Oct;4(10):e492. doi: 10.1016/S2468-2667(19)30165-3. Epub 2019 Aug 23. No abstract available.

2.

Availability of essential diagnostics in primary care in India.

Kohli M, Walia K, Mazumdar S, Boehme CC, Katz Z, Pai M.

Lancet Infect Dis. 2018 Oct;18(10):1064-1065. doi: 10.1016/S1473-3099(18)30539-5. No abstract available.

PMID:
30303097
3.

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.

Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, Hall SL, Chakravorty S, Cirillo DM, Tukvadze N, Bablishvili N, Stevens W, Scott L, Rodrigues C, Kazi MI, Joloba M, Nakiyingi L, Nicol MP, Ghebrekristos Y, Anyango I, Murithi W, Dietze R, Lyrio Peres R, Skrahina A, Auchynka V, Chopra KK, Hanif M, Liu X, Yuan X, Boehme CC, Ellner JJ, Denkinger CM; study team.

Lancet Infect Dis. 2018 Jan;18(1):76-84. doi: 10.1016/S1473-3099(17)30691-6. Epub 2017 Nov 30. Erratum in: Lancet Infect Dis. 2018 Feb 21;:.

4.

Diagnostic preparedness for infectious disease outbreaks.

Perkins MD, Dye C, Balasegaram M, Bréchot C, Mombouli JV, Røttingen JA, Tanner M, Boehme CC.

Lancet. 2017 Nov 11;390(10108):2211-2214. doi: 10.1016/S0140-6736(17)31224-2. Epub 2017 May 31.

PMID:
28577861
5.

Diagnosis of opportunistic infections: HIV co-infections - tuberculosis.

Scott L, da Silva P, Boehme CC, Stevens W, Gilpin CM.

Curr Opin HIV AIDS. 2017 Mar;12(2):129-138. doi: 10.1097/COH.0000000000000345. Review.

6.

Tuberculosis prevention must integrate technological and basic care innovation.

Albert H, Nathavitharana RR, Denkinger CM, Isaacs C, Boehme CC.

Eur Respir J. 2016 Nov;48(5):1531-1532. doi: 10.1183/13993003.01601-2016. No abstract available.

7.

Tuberculosis.

Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, Ginsberg A, Swaminathan S, Spigelman M, Getahun H, Menzies D, Raviglione M.

Nat Rev Dis Primers. 2016 Oct 27;2:16076. doi: 10.1038/nrdp.2016.76. Review.

PMID:
27784885
8.

Tuberculosis Diagnostics: State of the Art and Future Directions.

Pai M, Nicol MP, Boehme CC.

Microbiol Spectr. 2016 Oct;4(5). doi: 10.1128/microbiolspec.TBTB2-0019-2016. Review.

9.

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?

Albert H, Nathavitharana RR, Isaacs C, Pai M, Denkinger CM, Boehme CC.

Eur Respir J. 2016 Aug;48(2):516-25. doi: 10.1183/13993003.00543-2016. Epub 2016 Jul 13. Review.

10.

Feasibility and Operational Performance of Tuberculosis Detection by Loop-Mediated Isothermal Amplification Platform in Decentralized Settings: Results from a Multicenter Study.

Gray CM, Katamba A, Narang P, Giraldo J, Zamudio C, Joloba M, Narang R, Paramasivan CN, Hillemann D, Nabeta P, Amisano D, Alland D, Cobelens F, Boehme CC.

J Clin Microbiol. 2016 Aug;54(8):1984-91. doi: 10.1128/JCM.03036-15. Epub 2016 May 18.

11.

Market assessment of tuberculosis diagnostics in India in 2013.

Maheshwari P, Chauhan K, Kadam R, Pujani A, Kaur M, Chitalia M, Dabas H, Perkins MD, Boehme CC, Denkinger CM, Raizada N, Ginnard J, Jefferson C, Pantoja A, Rupert S, Kik SV, Cohen C, Chedore P, Satyanarayana S, Pai M; TB Diagnostics Market Analysis Consortium.

Int J Tuberc Lung Dis. 2016 Mar;20(3):304-13. doi: 10.5588/ijtld.15.0571.

PMID:
27046709
12.

Market assessment of tuberculosis diagnostics in China in 2012.

Zhao YL, Pang Y, Xia H, Du X, Chin D, Huan ST, Dong HY, Zhang ZY, Ginnard J, Perkins MD, Boehme CC, Jefferson C, Pantoja A, Qin ZZ, Chedore P, Denkinger CM, Pai M, Kik SV; TB Diagnostics Market Analysis Consortium.

Int J Tuberc Lung Dis. 2016 Mar;20(3):295-303. doi: 10.5588/ijtld.15.0156.

PMID:
27046708
13.

Target product profile of a molecular drug-susceptibility test for use in microscopy centers.

Denkinger CM, Dolinger D, Schito M, Wells W, Cobelens F, Pai M, Zignol M, Cirillo DM, Alland D, Casenghi M, Gallarda J, Boehme CC, Perkins MD.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S39-49. doi: 10.1093/infdis/jiu682. Review.

14.

Defining the needs for next generation assays for tuberculosis.

Denkinger CM, Kik SV, Cirillo DM, Casenghi M, Shinnick T, Weyer K, Gilpin C, Boehme CC, Schito M, Kimerling M, Pai M.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S29-38. doi: 10.1093/infdis/jiu821. Review.

15.

Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.

Cox HS, Mbhele S, Mohess N, Whitelaw A, Muller O, Zemanay W, Little F, Azevedo V, Simpson J, Boehme CC, Nicol MP.

PLoS Med. 2014 Nov 25;11(11):e1001760. doi: 10.1371/journal.pmed.1001760. eCollection 2014 Nov.

16.

Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis.

Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR.

Eur Respir J. 2014 Aug;44(2):435-46. doi: 10.1183/09031936.00007814. Epub 2014 Apr 2. Review.

17.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N.

Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593. doi: 10.1002/14651858.CD009593.pub3. Review. Update in: Cochrane Database Syst Rev. 2019 Jun 07;6:CD009593.

18.

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.

Friedrich SO, Rachow A, Saathoff E, Singh K, Mangu CD, Dawson R, Phillips PP, Venter A, Bateson A, Boehme CC, Heinrich N, Hunt RD, Boeree MJ, Zumla A, McHugh TD, Gillespie SH, Diacon AH, Hoelscher M; Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics (PanACEA).

Lancet Respir Med. 2013 Aug;1(6):462-70. doi: 10.1016/S2213-2600(13)70119-X. Epub 2013 Jul 1.

19.

Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies.

Lawn SD, Dheda K, Kerkhoff AD, Peter JG, Dorman S, Boehme CC, Nicol MP.

BMC Infect Dis. 2013 Sep 3;13:407. doi: 10.1186/1471-2334-13-407.

20.

Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action.

Wells WA, Boehme CC, Cobelens FG, Daniels C, Dowdy D, Gardiner E, Gheuens J, Kim P, Kimerling ME, Kreiswirth B, Lienhardt C, Mdluli K, Pai M, Perkins MD, Peter T, Zignol M, Zumla A, Schito M.

Lancet Infect Dis. 2013 May;13(5):449-58. doi: 10.1016/S1473-3099(13)70025-2. Epub 2013 Mar 24. Review.

21.

The changing landscape of diagnostic services for tuberculosis.

Boehme CC, Saacks S, O'Brien RJ.

Semin Respir Crit Care Med. 2013 Feb;34(1):17-31. doi: 10.1055/s-0032-1333468. Epub 2013 Mar 4. Review.

PMID:
23460003
22.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593. doi: 10.1002/14651858.CD009593.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(1):CD009593.

23.

Transforming TB diagnosis: can patients and control programs afford to wait?

Talbot EA, Pape JW, Sundaram L, Boehme CC, Perkins MD.

Am J Trop Med Hyg. 2012 Aug;87(2):202-4. doi: 10.4269/ajtmh.2012.12-0247. No abstract available.

24.

Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens.

Zar HJ, Workman L, Isaacs W, Munro J, Black F, Eley B, Allen V, Boehme CC, Zemanay W, Nicol MP.

Clin Infect Dis. 2012 Oct;55(8):1088-95. Epub 2012 Jul 2.

25.

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.

Vassall A, van Kampen S, Sohn H, Michael JS, John KR, den Boon S, Davis JL, Whitelaw A, Nicol MP, Gler MT, Khaliqov A, Zamudio C, Perkins MD, Boehme CC, Cobelens F.

PLoS Med. 2011 Nov;8(11):e1001120. doi: 10.1371/journal.pmed.1001120. Epub 2011 Nov 8.

26.

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

Blakemore R, Nabeta P, Davidow AL, Vadwai V, Tahirli R, Munsamy V, Nicol M, Jones M, Persing DH, Hillemann D, Ruesch-Gerdes S, Leisegang F, Zamudio C, Rodrigues C, Boehme CC, Perkins MD, Alland D.

Am J Respir Crit Care Med. 2011 Nov 1;184(9):1076-84. doi: 10.1164/rccm.201103-0536OC.

27.

Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study.

Nicol MP, Workman L, Isaacs W, Munro J, Black F, Eley B, Boehme CC, Zemanay W, Zar HJ.

Lancet Infect Dis. 2011 Nov;11(11):819-24. doi: 10.1016/S1473-3099(11)70167-0. Epub 2011 Jul 19.

28.

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD.

Lancet. 2011 Apr 30;377(9776):1495-505. doi: 10.1016/S0140-6736(11)60438-8. Epub 2011 Apr 18.

29.

Robustness of a loop-mediated isothermal amplification reaction for diagnostic applications.

Francois P, Tangomo M, Hibbs J, Bonetti EJ, Boehme CC, Notomi T, Perkins MD, Schrenzel J.

FEMS Immunol Med Microbiol. 2011 Jun;62(1):41-8. doi: 10.1111/j.1574-695X.2011.00785.x. Epub 2011 Mar 16.

30.

Rapid molecular detection of tuberculosis and rifampin resistance.

Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD.

N Engl J Med. 2010 Sep 9;363(11):1005-15. doi: 10.1056/NEJMoa0907847. Epub 2010 Sep 1.

31.

Evaluation of Diagnos TB AG, a flow-through immunoassay for rapid detection of pulmonary tuberculosis.

Reither K, Saathoff E, Jung J, Minja LT, Machibya H, Maboko L, Perkins MD, Hoelscher M, Boehme CC.

Int J Tuberc Lung Dis. 2010 Feb;14(2):238-40.

PMID:
20074417
32.

Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries.

Boehme CC, Nabeta P, Henostroza G, Raqib R, Rahim Z, Gerhardt M, Sanga E, Hoelscher M, Notomi T, Hase T, Perkins MD.

J Clin Microbiol. 2007 Jun;45(6):1936-40. Epub 2007 Mar 28.

33.

Congenital visceral leishmaniasis.

Boehme CC, Hain U, Novosel A, Eichenlaub S, Fleischmann E, Löscher T.

Emerg Infect Dis. 2006 Feb;12(2):359-60. No abstract available.

34.

A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.

Davioud-Charvet E, Delarue S, Biot C, Schwöbel B, Boehme CC, Müssigbrodt A, Maes L, Sergheraert C, Grellier P, Schirmer RH, Becker K.

J Med Chem. 2001 Nov 22;44(24):4268-76.

PMID:
11708927
35.

Assembly and functional expression of murine glutathione reductase cDNA: a sequence missing in expressed sequence tag libraries.

Iozef R, Becker K, Boehme CC, Schirmer RH, Werner D.

Biochim Biophys Acta. 2000 Jan 3;1500(1):137-41.

36.

The neural structure of Clarke's nucleus of the spinal cord.

Boehme CC.

J Comp Neurol. 1968 Mar;132(3):445-61. No abstract available.

PMID:
4173077

Supplemental Content

Loading ...
Support Center